{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:08:35Z","timestamp":1791065315059,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2013-2546"],"award-info":[{"award-number":["2013-2546"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["681712"],"award-info":[{"award-number":["681712"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish State Support for Clinical Research","award":["ALFGBG-441051"],"award-info":[{"award-number":["ALFGBG-441051"]}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"publisher","award":["FO2015-0021"],"award-info":[{"award-number":["FO2015-0021"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frimurarestiftelsen"},{"DOI":"10.13039\/100010815","name":"Stiftelsen Gamla Tj\u00e4narinnor","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF646211"],"award-info":[{"award-number":["AF646211"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sk\u00e5ne University Hospital (SUS) Foundations and Donations"},{"name":"Swedish Knowledge Foundation","award":["2014-0298"],"award-info":[{"award-number":["2014-0298"]}]},{"name":"Swedish Associations of Local Authorities and Regions"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neurobiolaging.2017.06.028","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T05:21:35Z","timestamp":1499750495000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients"],"prefix":"10.1016","volume":"59","author":[{"given":"Tobias","family":"Skillb\u00e4ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-3801","authenticated-orcid":false,"given":"Louise","family":"Delsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Synnergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"N\u00e4gga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Kilander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(83)90157-0","article-title":"Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia","volume":"60","author":"Alafuzoff","year":"1983","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer's disease - lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/1471-2458-14-643","article-title":"Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis","volume":"14","author":"Beydoun","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of Widespread BBB disruption in Alzheimer's disease models: Focus on Therapeutic Antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-015-0186-2","article-title":"Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy","volume":"3","author":"Blair","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors","volume":"81","author":"Blennow","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1600-0404.1991.tb04675.x","article-title":"White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors","volume":"83","author":"Blennow","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib9","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2012.03665.x","article-title":"Albumin is taken up by hippocampal NG2 cells and astrocytes and decreases gap junction coupling","volume":"53","author":"Braganza","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib10","first-page":"1067","article-title":"Isolated blood\u2013cerebrospinal fluid barrier dysfunction: prevalence and associated diseases","volume":"252","author":"Brettschneider","year":"2005","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/NEN.0000000000000124","article-title":"Blood-brain barrier dysfunction and cerebral small vessel disease (Arteriolosclerosis) in brains of older People","volume":"73","author":"Bridges","year":"2014","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000321965","article-title":"Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome","volume":"65","author":"Brouns","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-150499","article-title":"Cardiovascular diseases in \u223c30,000 patients in the Swedish dementia Registry","volume":"48","author":"Cermakova","year":"2015","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.clineuro.2012.11.005","article-title":"Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study","volume":"115","author":"De Reuck","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-0404.1986.tb07863.x","article-title":"Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome","volume":"74","author":"Elovaara","year":"1986","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood-brain barrier: ageing and microvascular disease\u2013systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/000456327701400118","article-title":"Hydrodynamic radii versus molecular weights in clearance studies of urine and cerebrospinal fluid","volume":"14","author":"Felgenhauer","year":"1977","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib20","doi-asserted-by":"crossref","first-page":"428.e7","DOI":"10.1016\/j.neurobiolaging.2010.11.014","article-title":"Demyelination of superficial white matter in early Alzheimer's disease: a magnetization transfer imaging study","volume":"33","author":"Fornari","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2353\/ajpath.2010.090482","article-title":"Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations","volume":"176","author":"Gama Sosa","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","article-title":"Cerebrovascular pathology during the progression of experimental Alzheimer's disease","volume":"88","author":"Giannoni","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"11 Suppl 1","key":"10.1016\/j.neurobiolaging.2017.06.028_bib23","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","article-title":"Risk factors for vascular dementia and Alzheimer disease","volume":"35","author":"Gorelick","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J.\u00a0Cereb. Blood flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00002093-199706000-00004","article-title":"Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets","volume":"11","author":"Hampel","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/15672050113109990156","article-title":"Impact of apolipoprotein E on Alzheimer's disease","volume":"10","author":"Hauser","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.wad.0000213814.43047.86","article-title":"Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County Study","volume":"20","author":"Hayden","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib28","doi-asserted-by":"crossref","first-page":"e105000","DOI":"10.1371\/journal.pone.0105000","article-title":"CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease","volume":"9","author":"Hermann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/0894-4105.13.1.31","article-title":"The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study","volume":"13","author":"Hodges","year":"1999","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2004.07.071","article-title":"Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus","volume":"369","author":"Hovsepyan","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2014.00088","article-title":"Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia","volume":"6","author":"Hsu","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157340009788167347","article-title":"Modifiable Midlife risk factors for late-life cognitive impairment and dementia","volume":"5","author":"Hughes","year":"2009","journal-title":"Curr. Psychiatry Rev."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","article-title":"The APOE varepsilon4\/varepsilon4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients","volume":"33","author":"Hultman","year":"2013","journal-title":"J.\u00a0Cereb. Blood flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib35","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat. Commun."},{"issue":"Pt 2","key":"10.1016\/j.neurobiolaging.2017.06.028_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awl317","article-title":"TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis","volume":"130","author":"Ivens","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-101878","article-title":"Cerebrospinal fluid biomarkers for Alzheimer's disease: diagnostic performance in a homogeneous mono-center population","volume":"24","author":"Johansson","year":"2011","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1468-1331.2009.02808.x","article-title":"Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study","volume":"17","author":"Jonsson","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib40","doi-asserted-by":"crossref","first-page":"e84405","DOI":"10.1371\/journal.pone.0084405","article-title":"Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia","volume":"8","author":"Karch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0197-4580(87)90053-4","article-title":"CSF and serum concentrations of albumin and IgG in Alzheimer's disease","volume":"8","author":"Kay","year":"1987","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.STR.29.9.1816","article-title":"Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men","volume":"29","author":"Kilander","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib43","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ (Clinical Res. Ed.)"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)62995-1","article-title":"Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls","volume":"167","author":"Kumar-Singh","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-016-0564-9","article-title":"Albumin and multiple sclerosis","volume":"16","author":"LeVine","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","article-title":"Increased albumin CSF\/serum ratio in dementia with Lewy bodies","volume":"358","author":"Llorens","year":"2015","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.parkreldis.2011.05.017","article-title":"Dementia associated with Parkinson's disease: applying the movement disorder Society Task force criteria","volume":"17","author":"Martinez-Martin","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12916-016-0676-5","article-title":"Post-mortem assessment in vascular dementia: advances and aspirations","volume":"14","author":"McAleese","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib50","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE epsilon4: the most prevalent yet understudied risk factor for Alzheimer's disease","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimer's Demen."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib54","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib57","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: the Rotterdam Study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib58","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/gps.2277","article-title":"Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests","volume":"24","author":"Palmqvist","year":"2009","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib59","doi-asserted-by":"crossref","first-page":"40331","DOI":"10.1038\/srep40331","article-title":"Blood occludin level as a potential biomarker for early blood brain barrier damage following ischemic stroke","volume":"7","author":"Pan","year":"2017","journal-title":"Scientific Rep."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib60","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1300021110","article-title":"Innate immunity receptor CD36 promotes cerebral amyloid angiopathy","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1742-2094-9-188","article-title":"Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease","volume":"9","author":"Pisani","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nrl.2011.01.013","article-title":"Differential functioning of mini-mental test items according to disease","volume":"26","author":"Prieto","year":"2011","journal-title":"Neurologia (Barcelona, Spain)"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib64","doi-asserted-by":"crossref","first-page":"e0116538","DOI":"10.1371\/journal.pone.0116538","article-title":"SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice","volume":"10","author":"Religa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib65","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1038\/ncomms9164","article-title":"Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation","volume":"6","author":"Ryu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jnr.1242","article-title":"Neurofilament protein in cerebrospinal fluid: a marker of white matter changes","volume":"66","author":"Sjogren","year":"2001","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib68","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib69","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib70","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A\u00a0population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1468-1331.2012.03784.x","article-title":"EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia","volume":"19","author":"Sorbi","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood\u2013brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib73","series-title":"About SveDem, Swedish Dementia Registry","author":"SveDem","year":"2015"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib74","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/jcbfm.2015.76","article-title":"Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease","volume":"35","author":"Sweeney","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib75","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/STROKEAHA.110.611731","article-title":"Blood-brain barrier permeability abnormalities in vascular cognitive impairment","volume":"42","author":"Taheri","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1023\/A:1018945608888","article-title":"Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril","volume":"9","author":"Tang","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups","volume":"57","year":"1994","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-brain barrier leakage in patients with early Alzheimer disease","volume":"281","author":"van de Haar","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2169\/internalmedicine.37.509","article-title":"Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio","volume":"37","author":"Wada","year":"1998","journal-title":"Intern. Med. (Tokyo, Japan)"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib81","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","article-title":"Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis","volume":"53","author":"Waubant","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib82","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2013.159","article-title":"Vascular aspects of cognitive impairment and dementia","volume":"33","author":"Wiesmann","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimer's Demen."},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib84","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders : Diagnostic Criteria for Research","author":"World Health Organization","year":"1993"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp.2009.177667","article-title":"Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage","volume":"82","author":"Zanier","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.028_bib86","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017302300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017302300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T17:33:22Z","timestamp":1655660002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017302300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":85,"alternative-id":["S0197458017302300"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.028","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}